アカデシン
| メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01APOOR1170T |
5-Amino-1-(beta-D-ribofuranosyl)-1H-imidazole-4-carboxamide |
2627-69-2 |
250mg |
￥16800 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01APOOR1170T |
5-Amino-1-(beta-D-ribofuranosyl)-1H-imidazole-4-carboxamide |
2627-69-2 |
1g |
￥36000 |
2024-03-01 |
購入 |
|
東京化成工業
|
A2528 |
5-アミノイミダゾール-4-カルボキサミド1-β-D-リボフラノシド >98.0%(HPLC)
5-Aminoimidazole-4-carboxamide 1-β-D-Ribofuranoside
>98.0%(HPLC) |
2627-69-2 |
50mg |
￥10500 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
SAB1306034 |
IgG fraction of antiserum, buffered aqueous solution
ANTI-AMPK ALPHA2(C-TERMINAL) antibody produced in rabbit IgG fraction of antiserum, buffered aqueous solution |
2627-69-2 |
400μL |
￥89100 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
A9978 |
≥98% (HPLC), powder
AICAR ≥98% (HPLC), powder |
2627-69-2 |
5mg |
￥19600 |
2024-03-01 |
購入 |
アカデシン 化学特性,用途語,生産方法
外観
白色〜うすい褐色, 結晶〜粉末
溶解性
水に溶ける。
効能
抗悪性腫瘍薬, 血小板凝集抑制薬
使用上の注意
不活性ガス封入
化学的特性
Solid
使用
AICAR is a nucleoside analogue that is able to enter nucleoside pools and is able to significantly increase levels of adenosine during periods of ATP breakdown. Adenosine-regulating agents (ARAs) hav
e been recognized for therapeutic potential in myocardial ischemia. Cardioprotective.
定義
ChEBI: A 1-ribosylimidazolecarboxamide in which the carboxamide group is situated at position 4 of the imidazole ring, which is further substituted at position 5 by an amino group. A purine nucleoside analogue and activator of AMP-activated protein kinase, it is
is used for the treatment of acute lymphoblastic leukemia and is reported to have cardioprotective effects.
一般的な説明
Adenosine monophosphate?protein kinase (AMPK) activator 5-aminoimidazole-4-carboxamide?ribonucleotide?(AICAR)?modulates cellular energy. It regulates lipid and glucose metabolism, pro-inflammatory responses,?cytokine production,?cell proliferation and apoptosis. AICAR improves ischemia or reperfusion injury and kidney fibrosis in rats. It provides protection against acute tubular necrosis.
生物活性
Cell-permeable, allosteric activator of AMP-activated protein kinase (AMPK). Augments proliferation, differentiation and mineralization of osteoblastic MC3T3-EI cells and attenuates psychosine-induced expression of proinflammatory cytokines and iNOS in astrocytes.
Clinical claims and research
AICAR has proved in vivo anti-tumor effects in xenograft models. It is currently under clinical trial phase I/II to treat patients with chronic lymphocytic leukemia and has shown good safety and tolerability properties, although some side effects have been reported.
アカデシン 上流と下流の製品情報
原材料
準備製品
アカデシン 生産企業
Global( 336)Suppliers
2627-69-2(アカデシン)キーワード:
- 2627-69-2
- 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside,98%
- 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranosideAICAR
- 5-Aminomidazole-4-carboxamide-1-β-D-ribofuranoside
- AICAR
- AICA-RIBOSIDE
- 1-Deoxy-1-[(4-carbamoyl-5-amino-1H-imidazole)-1-yl]-β-D-ribofuranose
- 1-β-D-Ribofuranosyl-5-amino-1H-imidazole-4-carboxamide
- 5-Amino-1-β-D-ribofuranosyl-1H-imidazole-4-carboxamide
- AICA-β-D-Riboside
- 5-AMino-4-iMidazole
carboxaMide Riboside
- Arasine
- GP 1-110
- NSC 105823
- AICAR, Free Base
- 5-aMino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxyMethyl)tetrahydrofuran-2-yl)-1H-iMidazole-4-carboxaMide
- N1-(β-D-Ribofuranosyl)-5-aminoimidazole-4-carboxamide
- AICAR,5-Aminoimidazole-4-carboxamide 1-β-D-ribofuranoside, Acadesine, N1-(β-D-Ribofuranosyl)-5-aminoimidazole-4-carboxamide
- 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranose ,98%
- Acadesine(Aicar,NSC 105823)
- 5-Amino-4-carbamoyl-1-(beta-D-ribofuranosyl)-1H-imidazole, AICAR
- Acadesine/AICAR
- AICA, Acadesine, AICA-ribaoside
- 1H-IMidazole-4-carboxaMide,5-aMino-1-b-D-ribofuranosyl-
- 5′-AMP-activated protein kinase catalytic subunit alpha-1
- ANTI-AMPK ALPHA 1(C-TERMINAL) antibody produced in rabbit
- Z-RIBOSIDE
- 5-amino-1-beta-d-ribofuranosyl-1h-imidazole-4-carboxamid
- N1-(BETA-D-RIBOFURANOSYL)-5-AMINOIMIDAZOLE-4-CARBOXAMIDE
- 5-Amino-1beta-D-ribofuranosylimidazole-4-carboxamide
- 5-Amino-1-beta-ribofuranosyl-imidazole-4-carboxamide
- 4-アミノ-3-(β-D-リボフラノシル)-3H-イミダゾール-5-カルボアミド
- 1-デオキシ-1-(5-アミノ-4-カルバモイル-1H-イミダゾール-1-イル)-β-D-リボフラノース
- 5-アミノ-1-(β-D-リボフラノシル)-1H-イミダゾール-4-カルボアミド
- アカデシン
- 1-デオキシ-1-[(4-カルバモイル-5-アミノ-1H-イミダゾール)-1-イル]-β-D-リボフラノース
- AICA-リボシド
- アミノイミダゾールカルボキサミドリボフラノシド
- 5-アミノイミダゾール-4-カルボキシアミドリボヌクレオシド
- AICA-β-D-リボシド
- 5-アミノ-1-β-D-リボフラノシルイミダゾール-4-カルボキサミド
- 5-アミノ-1-β-D-リボフラノシル-1H-イミダゾール-4-カルボアミド
- 1-β-D-リボフラノシル-5-アミノ-1H-イミダゾール-4-カルボアミド
- 1-(β-D-リボフラノシル)-5-アミノ-1H-イミダゾール-4-カルボアミド
- 5-アミノイミダゾール-4-カルボキサミド-1-β-D-リボフラノシド
- アラシン
- 5-アミノイミダゾール-4-カルボキサミド1-β-D-リボフラノシド
- 5-アミノ-1-(β-D-リボフラノシル)-1H-イミダゾール-4-カルボキサミド
- 5-アミノ-1-Β-D-リボフラノシル-1H-イミダゾール-4-カルボキサミド
- AICAリボシド
- AMPK (Α2/Β2/Γ1)、活性型、HISタグ融合 ヒト
- [(2R,3S,4R,5R)-5-(4-カルバモイルイミダゾール-1-イル)-3,4-ジヒドロキシオキソラン-2-イル]メトキシホスホン酸
- 1-(5-O-ホスホノ-β-D-リボフラノシル)-1H-イミダゾール-4-カルボアミド
- {[(2R,3S,4R,5R)-5-(4-カルバモイル-1H-イミダゾール-1-イル)-3,4-ジヒドロキシオキソラン-2-イル]メトキシ}ホスホン酸